Pharmacokinetics of tramadol and the metabolite O‐desmethyltramadol in dogs
- 11 August 2004
- journal article
- clinical trial
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 27 (4), 239-246
- https://doi.org/10.1111/j.1365-2885.2004.00578.x
Abstract
Tramadol is an analgesic and antitussive agent that is metabolized to O-desmethyltramadol (M1), which is also active. Tramadol and M1 exert their mode of action through complex interactions between opiate, adrenergic, and serotonin receptors. The pharmacokinetics of tramadol and M1 were examined following intravenous and oral tramadol administration to six healthy dogs, as well as intravenous M1 to three healthy dogs. The calculated parameters for half-life, volume of distribution, and total body clearance were 0.80 +/- 0.12 h, 3.79 +/- 0.93 L/kg, and 54.63 +/- 8.19 mL/kg/min following 4.4 mg/kg tramadol HCl administered intravenously. The systemic availability was 65 +/- 38% and half-life 1.71 +/- 0.12 h following tramadol 11 mg/kg p.o. M1 had a half-life of 1.69 +/- 0.45 and 2.18 +/- 0.55 h following intravenous and oral administration of tramadol. Following intravenous M1 administration the half-life, volume of distribution, and clearance of M1 were 0.94 +/- 0.09 h, 2.80 +/- 0.15 L/kg, and 34.93 +/- 5.53 mL/kg/min respectively. Simulated oral dosing regimens at 5 mg/kg every 6 h and 2.5 mg/kg every 4 h predict tramadol and M1 plasma concentrations consistent with analgesia in humans; however, studies are needed to establish the safety and efficacy of these doses.Keywords
This publication has 33 references indexed in Scilit:
- Actions of tramadol on micturition in awake, freely moving ratsBritish Journal of Pharmacology, 2003
- Pharmacokinetic/Pharmacodynamic Modeling of the Antinociceptive Effects of (+)-Tramadol in the Rat: Role of Cytochrome P450 2D ActivityThe Journal of pharmacology and experimental therapeutics, 2003
- Metabolism of the analgesic drug, tramadol hydrochloride, in rat and dogXenobiotica, 2001
- TramadolDrugs, 2000
- Serum concentrations of tramadol enantiomers during patient‐controlled analgesiaBritish Journal of Clinical Pharmacology, 1999
- The analgesic tramadol has minimal effect on gastrointestinal motor functionBritish Journal of Clinical Pharmacology, 1997
- The analgesic tramadol has minimal effect on gastrointestinal motor functionBritish Journal of Clinical Pharmacology, 1997
- Analgesic efficacy and safety of tramadol enantiomers in comparison with the racemate: a randomised, double-blind study with gynaecological patients using intravenous patient-controlled analgesiaPain, 1995
- TramadolDrugs, 1993
- Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies: Sponsored by the American Association of Pharmaceutical Chemists, U.S. Food and Drug Administration, Fédération Internationale Pharmaceutique, Health Protection Branch (Canada) and Association of Official Analytical ChemistsInternational Journal of Pharmaceutics, 1992